Medical/Pharmaceuticals
AASLD 2022 | Ascentage Pharma to Announce Results from First-in-Human Study of IAP Antagonist APG-1387 in an Oral Report at the AASLD Annual Meeting
SUZHOU, China and ROCKVILLE, Md., Oct. 19, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it will release results from the Phase I fir...
2022-10-20 07:16
2272
SeekIn Presents New Data Supporting its Pan-cancer Early Detection Test at the Early Detection of Cancer Conference 2022
The large case-control study demonstrates that SeekInCare® has 68.0% sensitivity at 98.0% specificity in 27 different cancer types as a whole. In both retrospective and prospective studies, the solid performance of SeekInCare® puts it into best-in-class category of multi-cancer early detection (...
2022-10-19 20:30
1745
PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL
* F-18 Pivalate PET shows high uptake regardless of origin of primary tumour * F-18 Pivalate can be used to monitor cerebral metastases * Patients without previous external beam radiation show higher tumour uptake, while those previously treated show a trend towards lower uptake MELBOURNE, A...
2022-10-19 11:12
1901
STANDIGM TO ATTEND BIO-EUROPE® 2022
Standigm will present AI-driven drug discovery technology at the conference
CAMBRIDGE, England, Oct. 18, 2022 /PRNewswire/ -- Standigm
2022-10-19 01:50
2369
CARsgen Announces NDA Acceptance of BCMA CAR T Zevor-cel (CT053) by China NMPA
SHANGHAI, Oct. 18, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces thatthe National Medical Products Administration (NMPA) ofChina has a...
2022-10-18 20:50
3934
Zhiyi Biotech Received Clinical Approval from U.S. FDA for SK10 in Chemotherapy-induced Diarrhea
GUANGZHOU, China, Oct. 18, 2022 /PRNewswire/ -- Zhiyi Biotech announced that FDA has approved the Company's Investigational New Drug (IND) application to develop SK10 (InactivatedBacteroides fragilis) for the treatment of Chemotherapy-induced Diarrhea (CID) . The approval of this IND authorizes Z...
2022-10-18 20:35
1577
Axiomtek Unleashes IP69K/IP66-Rated 10.4" Stainless Steel Fanless Touch Panel Computer for Food Processing Industry - GOT810-316
TAIPEI, Oct. 17, 2022 /PRNewswire/ -- Axiomtek – a world-renowned leader relentlessly devoted in the research, development and manufacture of series of innovative and reliable industrial computer products of high efficiency – is pleased to announce theGOT810-316, a 10.4-inch stainless steel fanle...
2022-10-18 11:41
2128
Gracell Biotechnologies Doses First Patient in Phase 2 Portion of Registrational Phase 1/2 Clinical Trial Evaluating GC007g for Treatment of B-cell Acute Lymphoblastic Leukemia
Clinical trial assessing allogeneic, HLA-matched, donor-derived allogeneic CAR-T therapy SAN DIEGO, Calif., SUZHOU and SHANGHAI, China, Oct. 17, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicat...
2022-10-17 20:05
2108
PharmAbcine Announces Poster Presentations on Its anti-VISTA Antibody Candidate at SITC 2022
DAEJEON, South Korea, Oct. 17, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the Company will present preclinical data of PMC-309, one of the Company's first immuno-oncology dru...
2022-10-17 20:00
2250
PENTAX Medical launches the C2 CryoBalloon(TM) Ablation System in Canada for the treatment of Barrett's Esophagus.
MISSISSAUGA, ON, Oct. 14, 2022 /PRNewswire/ -- PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy solutions, announced today the Canadian launch of the C2 CryoBalloon™ Ablation System for the treatment of Barrett's Esophagus. "With the launch of C2 CryoBalloon A...
2022-10-15 03:57
2373
Tianfu International Biocity: Build Global Bioindustry-city
CHENGDU, China, Oct. 14, 2022 /PRNewswire/ -- On Oct.10, Chengdu Tianfu Global International Biocity saw the signing of ten project agreements totalling nearly 9B CNY in value and covering modern biopharmaceuticals, innovative chemical drugs, sophisticated medical apparatuses and other important f...
2022-10-14 20:48
1942
Fosun Pharma's MSCI ESG Rating Upgraded to A
SHANGHAI, Oct. 13, 2022 /PRNewswire/ -- The world's leading index company Morgan Stanley Capital International ("MSCI") recently announced its latest annual Environmental, Social and Governance ("ESG") rating results. In recognition of its outstanding performance in ESG,MSCI upgraded the ESG rati...
2022-10-14 08:26
4010
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of Individuals with Multiple System Atrophy
Australia now open for study of rare, rapidly progressive Parkinsonian Disorder MELBOURNE, Australia and SAN FRANCISCO, Oct. 13, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying t...
2022-10-13 22:25
2340
First in North America: Jolly Good Hosts Clinical VR Multi Seminar in Boston, Aiming for Mass Production of UGC Medical VR
At the Boston Convention Center on Tuesday, October 25, 2022 TOKYO, Oct. 13, 2022 /PRNewswire/ -- Jolly Good Inc. (Chuo-ku, Tokyo, CEO: Kensuke Joji, hereinafter referred to as "Jolly Good") will hold a large-scale seminar on clinical training VR produced by the UGC* medical VR platform "JOLLYGO...
2022-10-13 21:00
2178
Research Collaboration between Prof. Antonio Gasbarrini team at Gemelli Hospital and Asian Biotech companies, Coree and Dx&Vx
SEOUL, South Korea, Oct. 13, 2022 /PRNewswire/ -- According to International Diabetes Federation, approximately 537 million adults (20-79 years) are living with diabetes worldwide and 206 million adults of the Western Pacific region includingChina, Japan, and South Korea have diabetes in 2021. St...
2022-10-13 21:00
2154
Neurophth Therapeutics Conducts Special Interview with Dr. Satoshi Kashii on World Sight Day
WUHAN, China and SAN DIEGO, Calif., Oct. 13, 2022 /PRNewswire/ -- October 13th is World Sight Day.Today, Neurophth Therapeutics, Inc. has a special interview with Dr.Satoshi Kashii, Professor of Visual Sciences and Ophthalmology, Aichi Shukutoku University, President of Asian Neuro-Ophthalmology ...
2022-10-13 20:30
3183
Harbour BioMed Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Oct. 13, 2022 /PRNewswire/ -- Harbour BioMed (the "Company", HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...
2022-10-13 19:05
2208
Samsung Biologics obtains three global ISO certifications
* Receives accreditation for information security management system, information security in cloud services, and anti-bribery management systems * First global CDMO to be ISO 27001 and ISO 27017 certified * Earns Excellence Award for Integrated Management System from BSI for its performance ...
2022-10-13 19:00
2338
Guiyang's Wudang district shines in pharma sector
GUIYANG, Oct. 12, 2022 /PRNewswire/ -- A news report from chinadaily.com.cn: Southwest China's Guizhou province – one of the four main regions for traditional Chinese medicine materials production inChina – has abundant medicine resources and a long history in ethnic medicine, and these days, it...
2022-10-13 10:12
1673
United Imaging Ships Global Installations Number 20,000, 20,001 and 20,002 from its Houston Headquarters to New York City
Fresh off the heels of its recent IPO, the company continues its steady U.S. growth. HOUSTON, Oct. 12, 2022 /PRNewswire/ -- United Imaging, a global leader in producing advanced medical imaging and radiotherapy equipment, announced that it is now shipping its 20,000th installation and two additi...
2022-10-12 21:00
2050
Week's Top Stories
Most Reposted
Hong Leong Bank Unveils HLB opus Extended Exclusively by Private Invitation
[Picked up by 320 media titles]
2026-09-03 23:53
Agoda Named Official Travel Partner of Eurovision's Inaugural Asian Edition
[Picked up by 313 media titles]
2026-09-02 12:17
Visa Launches Enhanced A2A Protect Innovations to Help Financial Institutions Stop Fraud Before Money Leaves Accounts
[Picked up by 311 media titles]
2026-09-02 08:30TEATER BESAR TAMAN ISMAIL MARZUKI SIMPLIFIES WIRELESS WORKFLOWS WITH SENNHEISER SPECTERA
[Picked up by 283 media titles]
2026-09-03 10:00
From Micro-Weddings to Milestones: Celebrating Life's Special Moments at Four Seasons Resorts of Asia
[Picked up by 282 media titles]
2026-09-04 10:43
Most Read
YY Group Enters New Era as YYForce, Expanding AI, Automation and Human-Robot Workforce Strategy; Nasdaq Ticker Changes to "YFOR"
2026-09-01 04:10
9707
Agoda Named Official Travel Partner of Eurovision's Inaugural Asian Edition
2026-09-02 12:17
9706
Klook Takes Creator Commerce Beyond Influence With Kreator Shops
2026-09-01 11:00
9663
